Product/Service
Clinical Research: Phase IIb - IV Clinical Trials
•Brochure: ICON Clinical Research
ICON Clinical Research specializes in the planning management, execution and analysis of Phase IIb - Phase IV clinical trials, ranging from small studies to complex, multinational projects.
ICON Clinical Research professionals apply their therapeutic, regulatory, and operational expertise to consistently solve the challenges that arise during all clinical projects. Our core competency is project management underpinned by comprehensive and consistent processes which conform to ISO 9001:2000 and a culture that is focused on delivering quality information to clients.
ICON has conducted over 1,000 clinical studies involving more than 295,000 patients in 31,000+ centres across the world, in all major therapeutic areas including CNS, Oncology, Cardiology, Transplant, Dermatology, Metabolic and Gastroenterology, Endocrinology, Infectious Diseases, Pain Management, Pediatrics, Respiratory, and Urology.
We place the highest importance on delivering quality data on time and on budget. Performance is monitored regularly and measured against contractual timelines. Project costs are measured per month on a project-by-project basis to ensure adherence to agreed budgets. Our primary approach is to use dedicated teams to achieve optimum results, but we can implement a range of resourcing models to suit client requirements.
Available separately or as part of a comprehensive clinical program, our integrated Clinical Research services cover a wide range of activities from protocol development and site identification through completion of study reports. Thus, every project is assured our complete focus from start to finish.
- Clinical Trials Management
- Biostatistics
- Data Management
- IVRS
- QA Services
- Medical Affairs & Drug Safety
- Patient Registries, Outcomes Research & Health Economics
•Brochure: ICON Clinical Research
